Superficial Cervical Plexus Block Versus Ketamine in the Prevention of Chronic Pain After Thyroidectomy
NCT ID: NCT07230392
Last Updated: 2025-11-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
69 participants
INTERVENTIONAL
2024-10-14
2025-07-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Perioperative Analgesic Efficiency of Bilateral Superficial Cervical Plexus Block in Patients With Thyroidectomy
NCT02680353
Ultrasound Guided Bilateral Superficial Cervical Plexus Block in Patients Undergoing Total Thyroidectomy.
NCT04993521
Cervical Erector Spinae Plane Block vs Cervical Plexus Block in Controlling Acute Postoperative Pain After Thyroidectomy
NCT06974630
Ultrasound Guided Bilateral Superficial Cervical Block for Post-operative Pain Therapy in Thyroid Surgery
NCT03109691
The Efficacy of Intermediate Cervical Plexus Block Versus Cutaneous and Thyroid Capsular Blocks
NCT03269890
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BCS Group
Patients received a bilateral ultrasound-guided superficial cervical plexus block after induction (Ropivacaine 0.2%,with a volume of 10 mL administered to each side)
Superficial cervical plexus block
Bilateral ultrasound-guided superficial cervical plexus block after induction(Ropivacaine 0.2% Ropivacaine 0.2%, with a volume of 10 mL administered to each side) was performed for patients of this group
KETA group
Patients received intravenous ketamine (0.25 mg/kg bolus followed by a 2 µg/kg/min infusion).
Ketamine perfusion
Intravenous ketamine 0.25 mg/kg bolus followed by a 2 µg/kg/min infusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ketamine perfusion
Intravenous ketamine 0.25 mg/kg bolus followed by a 2 µg/kg/min infusion
Superficial cervical plexus block
Bilateral ultrasound-guided superficial cervical plexus block after induction(Ropivacaine 0.2% Ropivacaine 0.2%, with a volume of 10 mL administered to each side) was performed for patients of this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for thyroidectomy under general anesthesia.
* American Society of Anesthesiologists (ASA) physical status I-III.
* Able to understand the study procedures and provide written informed consent
Exclusion Criteria
* Severe renal impairment with estimated Glomerular Filtration Rate (eGFR) under 30 mL/min
* History of neurological disorders
* History of psychiatric illness
* History of severe cardiac disease (NYHA III-IV) or serious arrhythmias
* Pregnancy or breastfeeding
* Morbid obesity (BMI \> 40 kg/m²)
* Cognitive or communication impairment
* Refusal to participate
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Tunis El Manar
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ben Taleb Ibtissem
Assistant Professor in Anesthesiology and Intensive Care
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ibtissem BEN TALEB
Role: PRINCIPAL_INVESTIGATOR
University of Tunis El Manar, Anesthesia and critical care department, Taher Maamouri University Hospital,
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mohamed Taher Maamouri University Hospital
Nabeul, Nabeul Governorate, Tunisia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Thyrobloket
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.